The Early Detection Research Group supports research that seeks to determine the effectiveness, operating characteristics and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.
Read more About the Early Detection Research Group.
Cancer Data Access System (CDAS)
Submission and tracking for data from the National Lung Screening Trial (NLST) and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
A repository of data from a large randomized trial on the effects of screening on cancer-related mortality and secondary endpoints in men and women aged 55 to 74.
The National Lung Screening Trial (NLST)
The National Lung Screening Trial (NLST) compared two ways of detecting lung cancer: participants who received low-dose helical CT scans had a 20% lower risk of dying from lung cancer than participants who received standard chest X-rays.
10th EDRN Scientific Workshop
This year's event entitled, "Cancer Biomarkers in Precision Medicine" will include both lectures and panel debates. Please see the announcement to learn more.